Cases & Deals

InSite Vision monetizes patent-related royalty stream

Clients InSite Vision Incorporated

Jones Day advised InSite Vision Incorporated, a developer of novel ophthalmic products designed to treat a growing range of common eye problems, in connection with the monetization of a patent-related royalty stream from future sales of Besivance® (besifloxacin opthalmic suspension), which is marketed globally by Bausch & Lomb for the treatment of bacterial conjunctivitis.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.